GCP
MXCT icon

GSA Capital Partners’s MaxCyte MXCT Stock Holding History

GSA Capital Partners’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Buy
+16,488
New +$15.4K ﹤0.01% 1652

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

GSA Capital Partners's MXCT Position: Q1 2026 in Review

GSA Capital Partners opened a new position in MaxCyte (MXCT) in Q1 2026: 16,488 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #1652 among its holdings.

130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • GSA Capital Partners held 16,488 shares of MaxCyte worth $12K as of Q1 2026.
  • MaxCyte was a new GSA Capital Partners position in Q1 2026.
  • MaxCyte made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1652 holding.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.